PPD has extensive experience in planning and implementing Phase I-IV programs for urology studies across multiple countries and sites. Between January 2004 and July 2009, we conducted or supported 77 protocols in urologic indications involving more than 17,700 patients at approximately 2,400 sites.
Our global investigator network includes more than 6,800 urologists, nephrologists, internists and obstetricians/gynecologists. Close working relationships with these investigators and sites ensure our ability to conduct a preliminary feasibility assessment quickly in order to predict enrollment and identify potential challenges for a viable protocol.
With global experience across multiple urology indications, we have conducted trials in recent years in the following: